1. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006;55((RR-17):1-37.
2. Ha YR, Goo HD, Kim SW, Jang SJ, Lee HS, Shim HS, Lee JW. Antitetanus antibody titers after toxoid injection. J Korean Soc Emerg Med 1996;7:202-206.
3. Kim KC, Kim CH, Kim HJ, Jeon IS, Seo HK. Doctors’ prescription behavior for tetanus prophylaxis in wound management. Korean J Fam Med 1996;17:492-500.
4. Kang JH. The need of Td vaccination according to the changes of tetanus and diphtheria immunity. J Korean Med Assoc 2008;51:127-136.
5. Social Security Information Service. Local health and medical information system [Internet] Seoul: Social Security Information Service. 2016;cited 2016 Dec 5. Available from:
http://bit.ly/2a2wh59
6. Centers for Disease Control and Prevention. Tetanus surveillance: United States, 2001-2008. MMWR Morb Mortal Wkly Rep 2011;60:365-369.
7. Kim HJ, Kang GH, Kim GW, Kim SC, Kim YS, Kim CH, Ahn HC, Oh SH, Yoon YS, Lee KH, Lee SW, Lee JB, Lee JW, Im TH, Chung JB, Cho SH, Cho KW, Cho JH, Cho JK, Choi MS, Hong ES, Lee YH. Korean Multicenter Study of Te tanus Antibody Titer (KoMUST). J Korean Soc Emerg Med 2005;16:667-676.
8. Yoon YS, Kim EC, Lee WH, Chung SW, Yi JH, Park IC, Shim HS. Utility of Tetanos Quick Stick(R) test for selective tetanus prophylaxis. J Korean Soc Emerg Med 2004;15:95-101.
9. Kang JH, Kim HB, Sohn JW, Lee SO, Chung MH, Cheong HJ, Choi YH, Choi JH, Choi JY, Choe HJ. Adult immunization schedule recommended by the Korean Society of Infectious Diseases, 2007. Infect Chemother 2008;40:1-13.
10. Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol 1994;97:Suppl 1. 79-83.
11. Kim JO. A clinical survey of tetanus. J Korean Surg Soc 1975;17:45-50.
12. Kim SK, Choi SC, Cho TH. A clinical analysis on tetanus. J Korean Surg Soc 1988;34:17-23.
13. Lee YH, Han DJ. A clinical analysis of tetanus. J Korean Surg Soc 1991;40:77-87.
14. Lee HY, Moon JM, Min YI, Chun BJ, Koh YS, Lee BG. Clinical manifestations and prognostic factors for tetanus in the emergency department. J Korean Soc Emerg Med 2007;18:143-149.
15. Lee JE, Lee SY. Evaluation of SD BIOLINE tetanus kit. Korean J Lab Med 2007;27:192-196.
16. Sohn YD, Lim KS, Choi WJ, Ahn JY, Kim W, Choi YB, Hong ES. Qualitative analysis of antitetanus antibody titers in Korean. J Korean Soc Traumatol 2004;17:27-36.
18. Korea Centers for Disease Control and Prevention. Disease and health integrated management system [Internet] Cheongju: Korea Centers for Disease Control and Prevention. 2016;cited 2016 Dec 5. Available from:
http://is.cdc.go.kr/
19. Otsuka SH, Tayal NH, Porter K, Embi PJ, Beatty SJ. Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record. Am J Med 2013;126:832.
20. Stinchfield PK. Practice-proven interventions to increase vaccination rates and broaden the immunization season. Am J Med 2008;121:7 Suppl 2. S11-S21.